ResMed (RMD) Tops Q2 EPS by 3c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $194.78 +1.24%
EPS Growth %: +13.3%
Financial Fact:
Diluted weighted average shares outstanding: 142.09M
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: +13.3%
Financial Fact:
Diluted weighted average shares outstanding: 142.09M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q2 EPS of $0.69, $0.03 better than the analyst estimate of $0.66. Revenue for the quarter came in at $454.5 million versus the consensus estimate of $446.25 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS Reiterates Neutral Rating on Clorox (CLX) as External Challenges Persist
- MIND Technology (MIND) Misses Q1 EPS by 5c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
